Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib
scientific article
Author/s
author: Francesca Palandri, Simona Soverini, Nicoletta Testoni, Gianantonio Rosti, Fausto Castagnetti, Giovanni Martinelli, Gabriele Gugliotta, Michele Baccarani, Simona Luatti, Ilaria Iacobucci, Caterina De Benedittis, Giulia Marzocchi, Alessandra Gnani
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.